Daniel Anthony Sterling, M.D.
NPI 1629069216ActiveIndividual· Surgery, Plastic and Reconstructive Surgery· Bedford, NH
Opted out of Medicare from October 2022 to October 2028. Surgery, Plastic and Reconstructive Surgery (M.D.) in Bedford, New Hampshire, licensed in NH, with an NPI issued in November 2005. Part D covered 31 prescriptions written in 2024, 90% of them generic. Janssen Biotech, Inc. was the largest of 5 companies reporting payments in 2025, $168.20 in all, mostly food and beverage.
Overview
| NPI | 1629069216 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Nov 2, 2005 |
| Last updated in NPPES | Nov 25, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Surgery, Plastic and Reconstructive Surgery Primary | 2086S0122X | 12586 | NH |
| Plastic Surgery | 208200000X | 12586 | NH |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Oct 1, 2022 – Oct 1, 2028 |
| Can order and refer | No |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 31 · 31 30-day fills |
|---|---|
| Patients | 12 |
| Total drug cost | $85.35 |
| Generic share | 90% of claims |
Industry payments (Open Payments)
- 2025$168.20 · 7 payments from 5 companies
- 2024$455.88 · 10 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Biotech, Inc. | $89.23 | 3 |
| Regeneron Healthcare Solutions, Inc. | $24.73 | 1 |
| Ipsen Biopharmaceuticals, Inc | $20.71 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.83 | 1 |
| Vertex Pharmaceuticals Incorporated | $16.70 | 1 |
What the 2025 payments were for
- Food and Beverage$168.20 · 7 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records